Rani Berry, MD
Gastroenterology · Burlingame
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 9
- 1 carrier
- Offices
- 4
Offices
4 locations · Sutter Bay Medical Foundation · 3,783 clinicians in this group
Looking this up.
Hospitals listed: Mills-Peninsula Medical Center. That is not proof they admit you there this week.
Plans that list them
9 plans · 1 carrier
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Berry’s office to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
| Alignment Health BreathEasy (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Clarity (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Harmony (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes CalPlus (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes Care (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Heart & Diabetes Choice (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Honor+ Plan (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health My Choice CalCare (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
California Medical Board record
Licence A161171 · Current
Licensed to practise in California · since 2019 · expires 2027-03-31 · Albany Medical College.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Hospitals they work in
1 hospital
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Peninsula Medical CenterBurlingame, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency department · Birthing-friendlyPart of Sutter Health, which runs 27 hospitals in 2 statesPatients rate it 4 of 5 · 78% would definitely recommend itOverall rating: 5 of 5 starsBetter than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.139, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.242, Oct 2024 – Sep 2025
See every measure and the patient survey for Peninsula Medical Center
Behind the star rating — Deaths: 2 better, 6 the same, 0 worse of 8 measures. Safety: 2 better, 5 the same, 0 worse of 7 measures. Readmissions: 0 better, 10 the same, 1 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.139 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.242 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.21 (0.27 to 2.15) · 1,258 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.81 (0.51 to 1.1) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 155.44 (112.67 to 198.21) · 90 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 2.5 · 32 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 7.1 · 82 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 10 · 188 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 9 · 473 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 14.8 · 342 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 9.4 · 485 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.9 · 3,730 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.2 (0 to 0.4) · 6,904 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.21 (0.02 to 0.4) · 7,052 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.41 (1.43 to 5.39) · 1,695 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.72 (0.17 to 3.28) · 665 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.11 (0.66 to 3.56) · 1,545 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 7.1 (1.3 to 12.9) · 670 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 5.96 (2.63 to 9.29) · 653 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.61 (0.15 to 3.08) · 418 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.14 (0 to 0.78) · 5,539 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.7 · 192 cases | None | Apr 2023 – Mar 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.215 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.263 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0.74 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 14.3 · 300 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 19 · 702 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 1.2 · 207 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -13.6 · 531 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 24.3 · 343 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 18.1 · 449 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 4.5 (2.8 to 7) · 85 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 9.6 (6.7 to 13.7) · 85 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.7 · 189 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 11 · 45 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20.6 · 117 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 13 (9.7 to 17.2) · 584 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.9 (0.7 to 1.2) · 764 cases | No different | Jan 2024 – Dec 2024 |
What patients said (523 patients answered, 27% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 4 |
| Overall hospital rating | 4 |
| Quietness | 3 |
| Recommend hospital | 5 |
| Room was "always" clean | 76% |
| Nurses "always" communicated well | 81% |
| Doctors "always" communicated well | 80% |
| Staff "always" explained | 58% |
| Yes, staff "did" give patients this information | 89% |
| Yes, staff "did" give patients information about help after discharge | 87% |
| Doctors "always" explained things so they could understand | 74% |
| Doctors "always" listened carefully | 79% |
| Doctors "always" treated them with courtesy and respect | 87% |
| Patients who gave a rating of "9" or "10" (high) | 75% |
| Staff "always" explained new medications | 72% |
| Nurses "always" explained things so they could understand | 77% |
| Nurses "always" listened carefully | 79% |
| Nurses "always" treated them with courtesy and respect | 88% |
| "Always" quiet at night | 54% |
| "YES", patients would definitely recommend the hospital | 78% |
| Staff "always" explained possible side effects | 44% |
| Yes, staff "did" give patients information about possible symptoms | 90% |
Original Medicare doctor bills
$30,119
Medicare paid this office $30,119 for 119 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| New patient visit (45+ min) | 38 | $5,298 | $139 |
| Removal of polyps or growths of large bowel using an endoscope with mechanical snare | 16 | $3,741 | $234 |
| Return visit (30+ min) | 20 | $3,451 | $119 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 19 | $2,729 | $144 |
| Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 19 | $1,931 | $97 |
See all 8 services
| New patient visit (45+ min) | 38 | $5,298 | $139 |
| Removal of polyps or growths of large bowel using an endoscope with mechanical snare | 16 | $3,741 | $234 |
| Return visit (30+ min) | 20 | $3,451 | $119 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 19 | $2,729 | $144 |
| Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 19 | $1,931 | $97 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 16 | $1,832 | $108 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 13 | $1,784 | $99 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 12 | $1,257 | $70 |
Procedures Medicare counted
| Colonoscopy | 41 | More than 59% of doctors who do this |
| Upper gastrointestinal (GI) endoscopy for acid reflux | 49 | More than 63% of doctors who do this |
Who their Medicare patients are
119 Original Medicare patients in 2024. Average age 77 · Women 65% · Also on Medicaid 10% · Health risk score 1.62. Above the middle of the specialty; the typical gastroenterology clinician is at 1.42.
Conditions among them: High blood pressure 72% · Chronic kidney disease 32% · Diabetes 29% · Coronary heart disease 29% · Atrial fibrillation 24% · Depression 24% · Heart failure 23% · Cancer 19% · COPD 15% · Dementia 10% · Stroke 10%.
The office billed $200,906, Medicare allowed $39,183 and paid $30,119; for 247 services of 29 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 119 | 247 | 77 | 1.62 | $200,906 | $30,119 |
| 2023 | 40 | 52 | 76 | 0.97 | $46,922 | $6,586 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 1 service
| New patient visit (45+ min) | 12 | $1,684 | $140 |
Drugs they prescribed that Part D paid
$76,554
Pharmacies billed $76,554 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their Part D prescriptions (0 of 125) in 2024. At or below the middle of the specialty; the typical gastroenterology clinician is at 0%.
90 generic and 35 brand-name prescriptions · $76,554 in drug cost.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Sod Sulf-Potass Sulf-Mag Sulf | 51 | $3,295 | $65 |
| Omeprazole | 27 | $965 | $36 |
| Famotidine | 13 | $286 | $22 |
| Pantoprazole | 14 | $269 | $19 |
Year by year
| 2024 | 125 | 74 | 0% (0) | 28% | $76,554 |
| 2023 | 33 | 26 | 0% (0) | 36% | $4,206 |
| 2022 | 24 | None | 0% (0) | None | $2,181 |
| 2021 | 24 | None | 0% (0) | None | $6,542 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 1 drug
| Sod Sulf-Potass Sulf-Mag Sulf | 13 | $839 | $65 |
Money from drug and device companies
$954 in 2025
| 2025 | 9 | 39 | None | $954 |
| 2024 | 10 | 22 | None | $747 |
| 2023 | 2 | 8 | None | $494 |
| 2022 | 3 | 10 | None | $817 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Abbvie | Skyrizi | $576 | 21 payments
|
| Celltrion USA | Vegzelma | $98 | 4 payments
|
| Pfizer | Xeljanz | $88 | 4 payments
|
| Takeda Pharmaceuticals U.S.A. | Entyvio | $56 | 2 payments
|
| Phathom Pharmaceuticals | Voquezna | $40 | 4 payments
|
| Lilly USA | Omvoh | $30 | 1 payment
|
See all 39 published payments
| Abbvie | Meals · 2025-12-17 | Rinvoq | $24 |
| Celltrion USA | Meals · 2025-12-03 | Vegzelma | $25 |
| Abbvie | Meals · 2025-12-01 | Creon | $29 |
| Abbvie | Meals · 2025-11-19 | Skyrizi | $26 |
| Ipsen Biopharmaceuticals | Meals · 2025-11-12 | Iqirvo | $23 |
| Abbvie | Education · 2025-11-05 | Skyrizi | $10 |
| Abbvie | Education · 2025-11-05 | Skyrizi | $10 |
| Abbvie | Meals · 2025-10-29 | Skyrizi | $23 |
| QOL Medical | Meals · 2025-10-22 | Sucraid | $15 |
| Abbvie | Meals · 2025-10-20 | Creon | $7 |
| Abbvie | Meals · 2025-10-17 | Rinvoq | $8 |
| Celltrion USA | Meals · 2025-09-24 | Vegzelma | $22 |
| Phathom Pharmaceuticals | Meals · 2025-09-17 | Voquezna | $20 |
| Phathom Pharmaceuticals | Meals · 2025-09-17 | Voquezna | $2 |
| Abbvie | Meals · 2025-09-04 | Creon | $30 |
| Abbvie | Meals · 2025-08-13 | Skyrizi | $24 |
| Pfizer | Meals · 2025-08-06 | Xeljanz | $32 |
| Takeda Pharmaceuticals U.S.A. | Meals · 2025-07-30 | Entyvio | $32 |
| Abbvie | Meals · 2025-07-23 | Linzess | $24 |
| Abbvie | Meals · 2025-07-16 | Skyrizi | $27 |
| Celltrion USA | Meals · 2025-07-01 | Vegzelma | $25 |
| Pfizer | Meals · 2025-06-12 | Xeljanz | $22 |
| Abbvie | Meals · 2025-06-11 | Linzess | $30 |
| Abbvie | Meals · 2025-06-05 | Skyrizi | $125 |
| Phathom Pharmaceuticals | Meals · 2025-06-05 | Voquezna | $17 |
| Phathom Pharmaceuticals | Meals · 2025-06-05 | Voquezna | $1 |
| Janssen Biotech | Meals · 2025-05-22 | Tremfya | $29 |
| Abbvie | Meals · 2025-05-15 | Rinvoq | $26 |
| Pfizer | Meals · 2025-05-07 | Xeljanz | $20 |
| Abbvie | Meals · 2025-04-24 | Skyrizi | $32 |
| Abbvie | Meals · 2025-04-22 | Creon | $9 |
| Abbvie | Meals · 2025-04-17 | Rinvoq | $21 |
| Abbvie | Meals · 2025-04-08 | Creon | $6 |
| Pfizer | Meals · 2025-03-13 | Xeljanz | $14 |
| Celltrion USA | Meals · 2025-02-11 | Vegzelma | $25 |
| Abbvie | Meals · 2025-02-07 | Rinvoq | $57 |
| Abbvie | Meals · 2025-02-06 | Rinvoq | $29 |
| Takeda Pharmaceuticals U.S.A. | Meals · 2025-02-05 | Entyvio | $24 |
| Lilly USA | Meals · 2025-01-30 | Omvoh | $30 |
See earlier years (2024, 2023, 2022)
2024: $747
| Abbvie | Skyrizi | $259 | 7 payments
|
| Lilly USA | Omvoh | $158 | 2 payments
|
| Janssen Biotech | Stelara | $99 | 3 payments
|
| Celltrion USA | Vegzelma | $53 | 2 payments
|
| Pfizer | Xeljanz | $46 | 2 payments
|
| QOL Medical | Sucraid | $41 | 2 payments
|
| Fresenius Kabi USA | Idacio | $32 | 1 payment
|
| Merck Sharp & Dohme | Dificid | $24 | 1 payment
|
| Phathom Pharmaceuticals | Voquezna | $19 | 1 payment
|
| Aimmune Therapeutics | Zenpep | $17 | 1 payment
|
2023: $494
| Abbvie | Skyrizi | $453 | 6 payments
|
| QOL Medical | Sucraid | $41 | 2 payments
|
2022: $817
| Abbvie | Rinvoq | $586 | 8 payments
|
| Olympus America | Endocuff Vision | $149 | 1 payment
|
| Allergan | None | $83 | 1 payment
|
Professional record
- NPI
- 1821521774
- Licence
- CA A161171California A161171: Current · expires 2027-03-31
- Video visits
- Lists video visits
- Gender
- Female
More record details
- Sole proprietor
- No
- Taxonomy
- Federal specialty code 207RG0100X (207RG0100X)
- Mailing address
- 325 Distel Cir, Los Altos, CA, 94022
- NPI first listed
- 2017-04-07
- NPI last updated
- 2023-09-26
- NPI record certified
- 2023-09-26
This is when the NPI record was last certified, not a medical board exam.
Extra NPI addresses: 757 Westwood Plz, Los Angeles, CA, 90095